Subscribe To

Price Alert Latest News Economic Calendar News

CHHHF / CareRx earns repeat ‘Buy' rating from Canaccord analysts with reduced price target following equity financing

Canaccord Genuity (TSX:CF, LSE:CF) analysts have reiterated their ‘Buy' rating for CareRx Corporation (TSX:CRRX) but reduced their price target after the Canadian healthcare company raised equity financing. CareRx announced on January 18 it completed a bought deal offering and closed the first tranche of a concurrent private placement for aggregate gross proceeds of around $12.1 million. Read More

Demo Live Account See Partner Details

Content Topics

Carerx

Earns

Repeat

Buy

Rating

From

Canaccord

Analysts

buy

Reduced

Target

Following

Equity

Financing

Stock

CHHHF

Posted: Jan 19 2023, 13:48

Author Name: Proactive Investors

CHHHF News

By Proactive Investors
March 9, 2023

CareRx Corporation posts 4Q 2022 results reflecting a year of "exceptional progress"

CareRx Corporation (TSX:CRRX) has reported its financial results for the fourth quarter ended December 31, 2022, during which a key success was winnin

By Proactive Investors
January 19, 2023

CareRx earns repeat ‘Buy' rating from Canaccord analysts with reduced price target following equity financing

Canaccord Genuity (TSX:CF, LSE:CF) analysts have reiterated their ‘Buy' rating for CareRx Corporation (TSX:CRRX) but reduced their price target aft

By Proactive Investors
January 18, 2023

CareRx closes $12.1 million financing to boost treasury

CareRx Corporation (TSX:CRRX) announced that it has completed its bought deal public offering and closed the first tranche of the concurrent private p

By Proactive Investors
November 9, 2022

CareRx's 3Q results "solid" in spite of inflationary headwinds and healthcare spending, analysts say

Long-term care pharmacy service provider CareRx Corporation (TSX:CRRX) has managed to withstand the macro challenges facing its business, according to

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.